Literature DB >> 1215678

Resistance in cattle to Fasciola hepatica induced by gamma-ray attenuated larvae: results from a controlled field trial.

P Nansen.   

Abstract

A significant resistance to natural infection in the field was obtained in calves inoculated with metacercariae of Fasciola hepatica attenuated at a gamma-irradiation level of 3 Krad. The mean fluke burden of vaccinated calves was 29 per cent of that of the controls. The resistance was reflected not only in reduced parasite burdens and low faecal egg counts, but also in the stability of gamma-glutamyltranspeptidase levels of the vaccinated calves compared with non-vaccinated controls. The gamma-ray dose of 3 Krad did not prevent a small proportion of the irradiated larvae reaching and maturing in the bile ducts.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1215678

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  5 in total

1.  Epizootiology, pathogenesis and immunoprophylactic trends to control tropical bubaline fasciolosis: an overview.

Authors:  R L Sharma; R Godara; M B Thilagar
Journal:  J Parasit Dis       Date:  2011-03-25

2.  A technique for in vivo labelling of Fasciola hepatica miracidia with radioselenium.

Authors:  P Nansen; N O Christensen; F Frandsen
Journal:  Z Parasitenkd       Date:  1976-03-31

3.  Protective effect of irradiated metacercariae of Fasciola gigantica and irradiated cercariae of Schistosoma bovis against fascioliasis in goats.

Authors:  A A el Sanhouri; E M Haroun; A A Gameel; H O Bushara
Journal:  Trop Anim Health Prod       Date:  1987-11       Impact factor: 1.559

Review 4.  The role of nuclear technologies in the diagnosis and control of livestock diseases--a review.

Authors:  Gerrit J Viljoen; Antony G Luckins
Journal:  Trop Anim Health Prod       Date:  2012-10       Impact factor: 1.559

Review 5.  Promising Technologies in the Field of Helminth Vaccines.

Authors:  Dilhan J Perera; Momar Ndao
Journal:  Front Immunol       Date:  2021-08-19       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.